During the past decade, Rutland Regional Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutland Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "University of Nebraska" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "CairnSurgical, Inc." with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutland Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Rutland Regional Medical Center" are "Breast Cancer" (4 trials), "Lung Cancer" (2 trials), "Prostate Cancer" (2 trials), "Stage IA Breast Cancer AJCC v7" (2 trials) and "Stage IB Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Rutland Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Rutland Regional Medical Center" are "Drug" (11 trials), "Other" (6 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Quality-of-Life Assessment" (3 trials), "Anastrozole" (2 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rutland Regional Medical Center" are 8 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rutland Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rutland Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rutland Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Rutland Regional Medical Center has several departments that took part in Clinical trials: "Community Cancer Center at Rutland Regional Medical Center" - 11 trials